Davidson Matt bought ADIL
October 28, 2026 · Form 4 insider transaction
Davidson Matt bought 286,044 shares of Adial Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
286,044
Price
N/A
Total value
N/A
InsiderDavidson Matt
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 28, 2026
Filing dateOctober 30, 2026
Shares owned after286,044
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Received in exchange for a stock option to acquire 896,272 shares of Old Azora common stock with an exercise price of $0.17 per share, which grant was subject to stockholder approval of the Preferred Stock Conversion Proposal. The Issuer's stockholders approved the Preferred Stock Conversion Proposal on the Conversion Proposal Approval Date.; Immediately exercisable.